Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Compact Ultralow Temperature Storage Solutions Available

By BiotechDaily International staff writers
Posted on 01 Jun 2014
Print article
Image: The Hamilton BIOS M Ultra-low Temperature Storage System (Photo courtesy of Hamilton Storage Technologies).
Image: The Hamilton BIOS M Ultra-low Temperature Storage System (Photo courtesy of Hamilton Storage Technologies).
A line of advanced deep freezers with robotic sample access is now available for biotech and life science laboratories.

The Hamilton Storage Technologies (Franklin, MA, USA) BiOS M and L are two compact high-density systems for the ultralow-temperature storage of sensitive biological samples.

All samples within the BiOS systems are stored in -80 degrees Celsius chest freezer compartments to maintain temperature stability. All internal workflows, including sample picking, are optimized to keep samples at ultralow temperatures at all times. System parts are easily accessible for service and maintenance, while one-dimensional and two-dimensional barcode reading and sample tracking provide complete chain-of-custody documentation—a requirement for forensic laboratories. Multiple backup systems ensure that samples stay at -80 degrees Celsius in the event of power failure.

“By adding smaller configurations of our high-capacity BiOS -80 degree Celsius storage system, more labs have access to state-of-the-art sample storage within steps of their sample preparation and analysis stations,” said Dr. Martin Frey, PhD, head of Hamilton Storage Technologies. “This reduces the likelihood that results may be compromised.”

Related Links:
Hamilton Storage Technologies



Print article

Channels

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.